Assessing anthracycline cardiotoxicity in the 1990s
- 1 April 1996
- journal article
- editorial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 23 (4) , 359-364
- https://doi.org/10.1007/bf01247361
Abstract
No abstract availableThis publication has 47 references indexed in Scilit:
- Pilot Study of Cardiac Function After Treatment of Childhood Wilms' Tumor with DoxorubicinPediatric Hematology and Oncology, 1995
- Assessment of anthracycline-related myocardial adrenergic derangement by [123i]metaiodobenzylguanidine scintigraphyEuropean Journal Of Cancer, 1995
- In-vivo and in-vitro mitochondrial membrane damages induced in mice by adriamycin and derivativesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1993
- Detection of Early Anthracycline Cardiotoxicity by Monitoring the Peak Filling RateAmerican Journal of Clinical Oncology, 1993
- Late Cardiac Toxicity of Doxorubicin, Epirubicin, and Mitoxantrone Therapy for Hodgkin's Disease in AdultsLeukemia & Lymphoma, 1993
- I-123 MIBG and Serial Radionuclide Angiocardiography in Doxorubicin-related CardiotoxicityClinical Nuclear Medicine, 1992
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapyThe American Journal of Medicine, 1987
- Prospective evaluation of doxorubicin cardiotoxicity by rest and exercise radionuclide angiographyThe American Journal of Cardiology, 1986
- Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide AngiocardiographyNew England Journal of Medicine, 1979